Form 8-K - Current report:
SEC Accession No. 0001792044-24-000022
Filing Date
2024-08-08
Accepted
2024-08-08 08:03:07
Documents
15
Period of Report
2024-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtrs-20240808.htm   iXBRL 8-K 26426
2 EX-99.1 exhibit991-2q24earningsrel.htm EX-99.1 655961
6 picture1.jpg GRAPHIC 4362
  Complete submission text file 0001792044-24-000022.txt   858877

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtrs-20240808.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtrs-20240808_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtrs-20240808_pre.xml EX-101.PRE 12520
17 EXTRACTED XBRL INSTANCE DOCUMENT vtrs-20240808_htm.xml XML 2806
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

EIN.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39695 | Film No.: 241186146
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)